AI-First Pharmatech Company, a game-changer in AI-driven drug developing process. We discover, design and develop the drug by sequence-based end-to-end AI solution.
- By integrating advanced AI technology and experts experience, Deargen is committed to discovering, designing and developing the best possible drugs in the fastest and most effective way.
- Deargen specializes in discovering the Hit/Lead compound regardless of the target protein’s 3D information by first applying transformer technology into the pharmaceutical field.
- Deargen members are experts in drug development, deep learning, software, biology, computational & medicinal chemistry, etc., for target discovery to lead optimization. Our end-to-end solution of AI platform allows saving time and cost compared to the traditional methods of drug discovery and development.
- Deargen assures you that we can meet your unmet scientific needs by providing technology and experiences to develop new drugs.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Administration B/d, 193, Munji-Ro, Yuseong-Gu, Daejeon,korea, Republic Of
- Phone
- 427162100
- co****@****rgen.me
- Industry
- It Services And It Consulting
- NAICS
-
Computer Systems Design and Related ServicesOther Computer Related Services
- Website
- deargen.me
- Keywords
- IT Consulting.
- HQ
- Daejeon
Deargen Questions
Deargen's helpline number is 427162100
Deargen's website is deargen.me
Deargen's LinkedIn profile is https://www.linkedin.com/company/deargen
Deargen has
12 employees.
View email and phone details for 12
employees at Deargen.
Deargen's industry is
IT Services and IT Consulting
Deargen's top competitors are
Tcc Steel Corp,
Attentionx,
Key Members,
Xcell Therapeutics (엑셀 세라퓨틱스),
Worv,
Amicogen,
Dr.noah Biotech,
Neurocle,
프렌츠,
Ktv 한국정책방송원.
Deargen's support email address is contact@deargen.me
Deargen's categories are IT Services and IT Consulting
Deargen's founding year is 2016
